ClearLight Biotechnologies, Inc. services

Long before your team will experience commercial success with your brand name drug, preclinical drug development activities take center stage. By the time you submit your investigational new drug (IND) application you’ll want to retire as many risks as possible and have confidence that your experimental drug will have its intended effects on the intended to treat population (ITT). Getting a strong drug candidate to the IND phase is a major step on your path to commercial success.